13F
中

GANX GAIN THERAPEUTICS INC

2026Q1 · CUSIP 36269B105 · Sector: Healthcare & Biotech

Neutral · No signal
Holders
40
Δ holders QoQ
-7
Breadth percentile
Top 82%
Whale holders
20
Δ whales
-5
Inst. holding value
$16M
New positions
9
Closed positions
16
Price momentum (1Q)
—
Put / Call
1/3

Breadth history (34 quarters)

2021Q2: Δ+2 · h=15 2021Q3: Δ+0 · h=15 2021Q4: Δ+5 · h=20 2022Q1: Δ-3 · h=17 2022Q2: Δ+0 · h=17 2022Q3: Δ+7 · h=24 2022Q4: Δ-2 · h=22 2023Q1: Δ+1 · h=23 2023Q2: Δ+2 · h=25 2023Q3: Δ+0 · h=25 2023Q4: Δ+0 · h=25 2024Q1: Δ+2 · h=27 2024Q2: Δ+2 · h=29 2024Q3: Δ-10 · h=19 2024Q4: Δ+6 · h=25 2025Q1: Δ+8 · h=33 2025Q2: Δ+2 · h=35 2025Q3: Δ+2 · h=37 2025Q4: Δ+10 · h=47 2026Q1: Δ-7 · h=40 2021Q2: holders=15 2021Q3: holders=15 2021Q4: holders=20 2022Q1: holders=17 2022Q2: holders=17 2022Q3: holders=24 2022Q4: holders=22 2023Q1: holders=23 2023Q2: holders=25 2023Q3: holders=25 2023Q4: holders=25 2024Q1: holders=27 2024Q2: holders=29 2024Q3: holders=19 2024Q4: holders=25 2025Q1: holders=33 2025Q2: holders=35 2025Q3: holders=37 2025Q4: holders=47 2026Q1: holders=40 -10 -5 +0 +5 +10 133250 21Q221Q422Q222Q423Q223Q424Q224Q425Q225Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 0 lit events

No lit events in history

Options Sentiment

Put holders
1
QoQ: -1
Call holders
3
QoQ: +1

See methodology →

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.58
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Quarterly Revenue & EPS (4Y)
2022-06-30: EPS -0.43 2022-09-30: EPS -0.38 2022-12-31: EPS -0.39 2023-03-31: EPS -0.43 2023-06-30: EPS -0.62 2023-09-30: EPS -0.37 2023-12-31: EPS -0.29 2024-03-31: EPS -0.22 2024-06-30: EPS -0.42 2024-09-30: EPS -0.17 2024-12-31: EPS -0.08 2025-03-31: EPS -0.16 2025-06-30: EPS -0.19 2025-09-30: EPS -0.15 2025-12-31: EPS -0.11 2026-03-31: EPS -0.13 -0.68 -0.34 0.00 20222023202420252026 EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)